Every investigation starts with one question: What did they try to hide? These days, the answer is usually buried somewhere in their digital life.

The challenge is that the evidence rarely lives in one place. A single investigation can involve cloud accounts, encrypted chats, surveillance footage and data from connected devices.

AI is making that trail even harder to follow, giving criminals new ways to create convincing scams and synthetic content while leaving investigators with even larger volumes of digital evidence to review.

Recovering and making sense of that evidence has become an industry of its own, and CellebriteCLBT

sits at the center of it. Think less Dexter and more digital forensics built to stand up in court.

Following the digital trail

Founded in 1999 as a mobile data transfer company, Cellebrite entered the digital forensics market in 2007 with the launch of its Universal Forensic Extraction Device.

Today, its software helps investigators recover deleted data, connect evidence across multiple sources, and manage digital evidence throughout an investigation.

The company's newest product, Genesis, extends that workflow with agentic AI built specifically for investigations. Rather than relying on a general-purpose large language model, it is trained on forensic file formats and investigative procedures.

Genesis handles much of the time-consuming work, including finding relevant communications, translating content, summarizing conversations, and tracing relationships across large datasets, while investigators remain responsible for judging the evidence.

Genesis can process call detail records, warrant returns, messages, images, video, and audio across more than 35 evidence formats, surfacing connections investigators might otherwise miss.

Cellebrite is also widening the scope of its platform. In July 2026, it expanded its exclusive partnership with SkySafe, combining drone data with mobile forensic evidence in a single platform.

The demand tailwind

Over 7K law enforcement agencies, defense organizations, and enterprises use Cellebrite's software, including 14 of the 15 US Cabinet Executive Departments. Those customers collectively conduct nearly 3M legally sanctioned investigations each year using the platform.

Evidence collected in the field flows directly into Guardian, Cellebrite's evidence management system. Guardian Investigate lets multiple agencies collaborate on the same case without compromising the integrity of the evidence.

The macro environment is reinforcing the demand. Americans reported nearly $21B in losses from cyber-enabled crime last year, including almost $900M tied to AI-enabled scams and fraud.

The National Center for Missing and Exploited Children handled 21.5M CyberTips last year, while reports of online enticement climbed 158%. Every complaint adds to the volume of digital evidence investigators must review, creating a growing need for tools like Genesis.

The investment case ahead

The investment case is not without risks. Cellebrite trades at roughly 52 times trailing earnings, leaving little room for disappointing growth.

The company also relies heavily on government and law enforcement contracts, making revenue sensitive to procurement cycles, budget priorities, and regulation.

Competition in digital forensics is also intensifying, raising the pressure to keep pace with advances in AI, encryption, and data recovery.

The biggest question is whether AI-generated investigative findings will hold up in court. Cellebrite says Genesis keeps investigators in control by limiting searches to the scope of a warrant, preserving the source of every finding and requiring human oversight throughout the process.

If agencies and courts accept that approach, the company will be in a strong position as AI becomes a larger part of digital investigations.

Regardless, analysts remain optimistic about Cellebrite's outlook. TD Cowen recently reaffirmed its Buy rating and $23 price target, while Wall Street maintains a Strong Buy consensus with an average target of $19.75.

The Q2 2026 earnings results on Aug. 13 will give investors their first look at whether Genesis adoption is beginning to translate into revenue.